These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 4123367)

  • 1. Cellular requirements for development of primary anti-hapten antibody responses in vitro.
    Bluestein HG; Pierce CW
    J Immunol; 1973 Jul; 111(1):137-42. PubMed ID: 4123367
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of primary M, G, and A anti-TNP plaque-forming cell responses in vitro.
    Bluestein HG; Pierce CW
    J Immunol; 1973 Jul; 111(1):130-6. PubMed ID: 4576584
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of the immune response. V. Antibody-mediated inhibition of T and B cell cooperation in the in vitro response to red cell antigens.
    Hoffmann MK; Kappler JW; Hirst JA; Oettgen HF
    Eur J Immunol; 1974 Apr; 4(4):282-6. PubMed ID: 4605029
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of allogeneic T lymphocytes and bacterial lipopolysaccharide to induce immune responses to monovalent haptens in vitro.
    Trenkner E
    J Immunol; 1974 Sep; 113(3):918-24. PubMed ID: 4153527
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of carrier modification on the cellular and serologic responses of the rat to the TNP hapten. I. Dependence of the immunogenicity of the antigen upon processing by macrophages, as well as upon the distribution and retention of the antigen.
    Hirsh DC; Amkraut AA; Steward JP
    J Immunol; 1972 Mar; 108(3):765-75. PubMed ID: 4551852
    [No Abstract]   [Full Text] [Related]  

  • 6. An in vivo primary response to 2,4,6-trinitrophenyl substituted erythrocytes.
    Pazdernik TL; Uyeki EM
    Immunology; 1973 May; 24(5):823-30. PubMed ID: 4577080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enhancement of a primary in vitro anti-hapten response by carrier priming.
    Trowbridge IS
    Eur J Immunol; 1972 Dec; 2(6):558-65. PubMed ID: 4569998
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of the immune response. IV. Antibody-mediated suppression of the immune response to haptens and heterologous erythrocyte antigens in vitro.
    Kappler JW; van der Hoven A; Dharmarajan U; Hoffmann M
    J Immunol; 1973 Oct; 111(4):1228-35. PubMed ID: 4580667
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell-dependent mediator in the immune response. III. The role of non-specific factor (NSF) in the in vitro immune response.
    Waldmann H
    Immunology; 1975 Mar; 28(3):497-507. PubMed ID: 1092612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier inhibition in the in vitor response to hapten-erythrocyte conjugate.
    Schwarze G; Pünter J
    Eur J Immunol; 1973 Nov; 3(11):742-4. PubMed ID: 4589171
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody production in mice. VI. Effect of anti-carrier antibody on cellular co-operation in the primary anti-hapten antibody response.
    Takatsu K; Hamaoka T; Kitagawa M
    Immunology; 1974 Feb; 26(2):233-46. PubMed ID: 4546728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hapten response in vitro. Affinity differences in precursors of anti-hapten antibody-producing cells.
    Pasanen VJ; Virolainen M
    Eur J Immunol; 1971 Nov; 1(5):406-8. PubMed ID: 4945641
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of immunity and tolerance in vitro by hapten protein conjugates. II. Carrier independence of the response to dinitrophenylated polymerized flagellin.
    Feldmann M
    Eur J Immunol; 1972 Apr; 2(2):130-7. PubMed ID: 4566300
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro immunity to TNP and penicillin: specific inhibition with hapten-conjugated isologous red cells.
    Naor D; Mishell R
    J Immunol; 1972 Jan; 108(1):246-52. PubMed ID: 4551578
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancing activity of synthetic polynucleotides on the induction of anti-hapten antibody response.
    Yamashita U; Kitagawa M
    Immunology; 1974 May; 26(5):925-36. PubMed ID: 4604433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of macrophage-bound antigens: the requirement for hapten and carrier determinants to be on the same molecule for T and B lymphocyte collaboration.
    Unanue ER; Katz DH
    Eur J Immunol; 1973 Sep; 3(9):559-63. PubMed ID: 4128975
    [No Abstract]   [Full Text] [Related]  

  • 17. The suppressive effect of antibodies on cellular cooperation.
    Kitagawa M; Hamaoka T; Takatsu K; Yamashita UY
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):467-75. PubMed ID: 4143456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thymus origin of the carrier-specific cell in an anti-hapten response in vitro.
    Trowbridge IS; Anderson HR
    Eur J Immunol; 1972 Dec; 2(6):565-70. PubMed ID: 4540163
    [No Abstract]   [Full Text] [Related]  

  • 19. Decline and spontaneous recovery of the monoclonal response to phosphorylcholine during repeated immunization.
    Lee W; Köhler H
    J Immunol; 1974 Nov; 113(5):1644-6. PubMed ID: 4608359
    [No Abstract]   [Full Text] [Related]  

  • 20. The Zipp assay: a method for enumerating cells producing anti-phage antibody.
    Tao TW; Dresser DW
    Eur J Immunol; 1972 Jun; 2(3):262-5. PubMed ID: 4675833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.